Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab

Eculizumab in Transplant-Associated Thrombotic Microangiopathy

(2016) Prajwal Dhakal et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Drug-induced thrombotic microangiopathy: a systematic review of published reports

(2014) Z. L. Al-Nouri et al.   BLOOD

Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature

(2014) Hye Won Lee et al.   Gut and Liver

Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the joint committee of the Japanese society of nephrology and the Japan pediatric society

(2013) Toshihiro Sawai et al.   Clinical and Experimental Nephrology

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mitomycin–C-Induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: Cumulative Toxicity of an Old Drug in a New Era

(2011) Roland El-Ghazal et al.   Clinical Colorectal Cancer

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

(2010) M. Noris et al.   Clinical Journal of the American Society of Nephrology

Posttransplantation Calcineurin Inhibitor–Induced Hemolytic Uremic Syndrome: Single-Center Experience

(2010) T. Said et al.   TRANSPLANTATION PROCEEDINGS

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE